CVE-2025-67108

CVE-2025-67108 is a critical-severity vulnerability in Eprosima Fast Dds with a CVSS 3.x base score of 10.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-298.

Key facts

Description

eProsima Fast-DDS v3.3 was discovered to contain improper validation for ticket revocation, resulting in insecure communications and connections.

Frequently asked questions

What is CVE-2025-67108?
eProsima Fast-DDS v3.3 was discovered to contain improper validation for ticket revocation, resulting in insecure communications and connections.
How severe is CVE-2025-67108?
CVE-2025-67108 has a CVSS 3.x base score of 10.0, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.
Is CVE-2025-67108 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (17th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-67108?
CVE-2025-67108 affects Eprosima Fast Dds. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-67108?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2025-67108 have an EU (EUVD) identifier?
Yes. CVE-2025-67108 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-204854.
When was CVE-2025-67108 published?
CVE-2025-67108 was published on 2025-12-23 and last updated on 2026-07-05.

References

EU advisories (EUVD)

Affected products (1)

More vulnerabilities in Eprosima Fast Dds

All CVEs affecting Eprosima Fast Dds →

Other CWE-298 vulnerabilities

Browse all CWE-298 vulnerabilities →